Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1363318
PUBLISHER: Grand View Research | PRODUCT CODE: 1363318
Nucleic Acid Amplification Testing Market Size, Share & Trends Analysis Report By Type (PCR, INAAT), By Application (Infectious Disease Testing, Oncology Testing), By End-use, By Region, And Segment Forecasts, 2023 - 2030
PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Nucleic Acid Amplification Testing Market Growth & Trends:
The global nucleic acid amplification testing market size is expected to reach USD 19.2 billion by 2030, registering a CAGR of 12.2% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Rising awareness regarding early detection of chronic and infectious diseases, and emerging technological advancements in PCR technology are the factors expected to significantly drive the market growth. In addition, the global rise in the prevalence of infectious diseases such as influenza, hepatitis, and sexually transmitted infections is anticipated to increase the demand for nucleic acid amplification testing and positively affect market growth.
Nucleic acid amplification testing has witnessed a high amount of investment in recent years due to its applicability to diagnose a variety of disease conditions, including life-threatening conditions such as cancer. For instance, the development of Cepheid's Gene Xpert technology involved a total public investment of over USD 252.0 million, including grants of more than USD 56.0 million from the National Institutes of Health, and around USD 73.0 million from other U.S. government departments.
Moreover, the high efficiency and accuracy of nucleic acid amplification testing have led to an increasing preference for the technique over traditional diagnostic options, such as culture-based identification. These attributes are boosting the growth of nucleic acid amplification testing technologies.
COVID-19 has increased demand for rapid and accurate testing methods, including nucleic acid amplification testing, for the detection of the SARS-CoV-2 virus. Key players involved in the market have developed new product offerings, such as isothermal nucleic acid amplification technology-based tests, to meet the high demand for rapid and point-of-care testing.
For instance, in March 2020, Abbott Laboratories received Emergency Use Authorization (EUA) for its Abbott ID NOW COVID-19 test which can deliver positive results within five minutes and negative results within 13 minutes. Such strategic initiatives fueled by the pandemic are expected to boost market growth in the near future.
Nucleic Acid Amplification Testing Market Report Highlights:
- Polymerase Chain Reaction (PCR) tests held the largest share of 66.7% in 2022 as the testing type allows for the high accuracy and multiplexing capabilities for the detection of a broad range of pathogens
- By application, infectious diseases accounted for the largest share of 46.4% in 2022. The rising prevalence of the infectious disease globally and efficient testing alternatives offered by nucleic acid amplification techniques are driving the segment
- North America held the largest share of 37.1% in 2022, due to the presence of an established healthcare sector and key players such as Abbott Laboratories; Illumina, Inc.; Bio-Rad Laboratories, Inc., and others in the region
- Central and reference laboratories end-use segment dominated the market in 2022 with a market share of 41.9% in 2022 due to the increasing healthcare investments and rising adoption of nucleic acid amplification tests for early disease diagnosis
Product Code: GVR-1-68038-388-1
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Type
- 1.1.2. Application
- 1.1.3. End-use
- 1.1.4. Regional scope
- 1.1.5. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.2.2. Application outlook
- 2.2.3. End-use outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Nucleic Acid Amplification Testing Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Market Dynamics
- 3.3.1. Market Driver Analysis
- 3.3.2. Market Restraint Analysis
- 3.4. Nucleic Acid Amplification Testing Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
- 3.4.1.1. Supplier power
- 3.4.1.2. Buyer power
- 3.4.1.3. Substitution threat
- 3.4.1.4. Threat of new entrant
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Technological landscape
- 3.4.2.3. Economic Landscape
- 3.4.1. Industry Analysis - Porter's
Chapter 4. Nucleic Acid Amplification Testing: Type Estimates & Trend Analysis
- 4.1. Nucleic Acid Amplification Testing Market: Key Takeaways
- 4.2. Nucleic Acid Amplification Testing Market: Movement & Market Share Analysis, 2022 & 2030
- 4.3. Polymerase Chain Reaction (PCR) Tests
- 4.3.1. Polymerase chain reaction (PCR) tests market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4. Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
- 4.4.1. Isothermal nucleic acid amplification technology (INAAT) tests market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5. Ligase Chain Reaction (LCR) Tests
- 4.5.1. Ligase Chain Reaction (LCR) Tests market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Nucleic Acid Amplification Testing: Application Estimates & Trend Analysis
- 5.1. Nucleic Acid Amplification Testing Market: Key Takeaways
- 5.2. Nucleic Acid Amplification Testing Market: Movement & Market Share Analysis, 2022 & 2030
- 5.3. Infectious Disease Testing
- 5.3.1. Infectious disease testing market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.3.2. Covid-19 Testing
- 5.3.2.1. Covid-19 testing market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.3.3. Mosquito Borne Disease Testing
- 5.3.3.1. Mosquito borne disease testing market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.3.4. Influenza Testing
- 5.3.4.1. Influenza testing market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.3.5. Sexually Transmitted Infectious Testing
- 5.3.5.1. Sexually transmitted infectious testing market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.3.6. Hepatitis Testing
- 5.3.6.1. Hepatitis testing market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.3.7. Tuberculosis Testing
- 5.3.7.1. Tuberculosis testing market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.3.8. Others
- 5.3.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4. Oncology Testing
- 5.4.1. Oncology testing market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.5. Genetic & Mitochondrial Disease Testing
- 5.5.1. Genetic & mitochondrial disease testing market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Nucleic Acid Amplification Testing: End Use Estimates & Trend Analysis
- 6.1. Nucleic Acid Amplification Testing Market: Key Takeaways
- 6.2. Nucleic Acid Amplification Testing Market: Movement & Market Share Analysis, 2022 & 2030
- 6.3. Hospitals
- 6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.4. Central and Reference Laboratories
- 6.4.1. Central and reference Laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.5. Others
- 6.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Nucleic Acid Amplification Testing Market: Regional Estimates & Trend Analysis
- 7.1. Regional Outlook
- 7.2. Nucleic Acid Amplification Testing Market by Region: Key Takeaways
- 7.3. North America
- 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.3.2. U.S.
- 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.3.3. Canada
- 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4. Europe
- 7.4.1. UK
- 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.2. Germany
- 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.3. France
- 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.4. Italy
- 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.5. Spain
- 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.6. Denmark
- 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.7. Sweden
- 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.8. Norway
- 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.1. UK
- 7.5. Asia Pacific
- 7.5.1. Japan
- 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.2. China
- 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.3. India
- 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.4. Australia
- 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.5. Thailand
- 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.6. South Korea
- 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.1. Japan
- 7.6. Latin America
- 7.6.1. Brazil
- 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6.2. Mexico
- 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6.3. Argentina
- 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6.1. Brazil
- 7.7. MEA
- 7.7.1. South Africa
- 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.2. Saudi Arabia
- 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.3. UAE
- 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.4. Kuwait
- 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.1. South Africa
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Market Participant Categorization
- 8.2.1. F. Hoffmann-La Roche Ltd
- 8.2.1.1. Company overview
- 8.2.1.2. Financial performance
- 8.2.1.3. Product benchmarking
- 8.2.1.4. Strategic initiatives
- 8.2.2. Becton, Dickinson and Company
- 8.2.2.1. Company overview
- 8.2.2.2. Financial performance
- 8.2.2.3. Product benchmarking
- 8.2.2.4. Strategic initiatives
- 8.2.3. Danaher Corporation
- 8.2.3.1. Company overview
- 8.2.3.2. Financial performance
- 8.2.3.3. Product benchmarking
- 8.2.3.4. Strategic initiatives
- 8.2.4. Abbott Laboratories
- 8.2.4.1. Company overview
- 8.2.4.2. Financial performance
- 8.2.4.3. Product benchmarking
- 8.2.4.4. Strategic initiatives
- 8.2.5. Illumina, Inc.
- 8.2.5.1. Company overview
- 8.2.5.2. Financial performance
- 8.2.5.3. Product benchmarking
- 8.2.5.4. Strategic initiatives
- 8.2.6. Siemens Healthineers
- 8.2.6.1. Company overview
- 8.2.6.2. Financial performance
- 8.2.6.3. Product benchmarking
- 8.2.6.4. Strategic initiatives
- 8.2.7. bioMerieux SA
- 8.2.7.1. Company overview
- 8.2.7.2. Financial performance
- 8.2.7.3. Product benchmarking
- 8.2.7.4. Strategic initiatives
- 8.2.8. Novartis AG
- 8.2.8.1. Company overview
- 8.2.8.2. Financial performance
- 8.2.8.3. Product benchmarking
- 8.2.8.4. Strategic initiatives
- 8.2.9. Bio-Rad Laboratories, Inc.
- 8.2.9.1. Company overview
- 8.2.9.2. Financial performance
- 8.2.9.3. Product benchmarking
- 8.2.9.4. Strategic initiatives
- 8.2.10. Seegene Inc.
- 8.2.10.1. Company overview
- 8.2.10.2. Financial performance
- 8.2.10.3. Product benchmarking
- 8.2.10.4. Strategic initiatives
- 8.2.1. F. Hoffmann-La Roche Ltd
Product Code: GVR-1-68038-388-1
List of Tables
- Table 1 List of Abbreviations
- Table 2 North America nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
- Table 3 North America nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
- Table 4 North America nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
- Table 5 North America nucleic acid amplification testing market, by region, 2018 - 2030 (USD Million)
- Table 6 U.S. nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
- Table 7 U.S. nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
- Table 8 U.S. nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
- Table 9 Canada nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
- Table 10 Canada nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
- Table 11 Canada nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
- Table 12 Europe nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
- Table 13 Europe nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
- Table 14 Europe nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
- Table 15 Europe nucleic acid amplification testing market, by region, 2018 - 2030 (USD Million)
- Table 16 Germany nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
- Table 17 Germany nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
- Table 18 Germany nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
- Table 19 UK nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
- Table 20 UK nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
- Table 21 UK nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
- Table 22 France nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
- Table 23 France nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
- Table 24 France nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
- Table 25 Italy nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
- Table 26 Italy nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
- Table 27 Italy nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
- Table 28 Spain nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
- Table 29 Spain nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
- Table 30 Spain nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
- Table 31 Denmark nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
- Table 32 Denmark nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
- Table 33 Denmark nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
- Table 34 Sweden nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
- Table 35 Sweden nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
- Table 36 Sweden nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
- Table 37 Norway nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
- Table 38 Norway nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
- Table 39 Norway nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
- Table 40 Asia Pacific nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
- Table 41 Asia Pacific nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
- Table 42 Asia Pacific nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
- Table 43 Asia Pacific nucleic acid amplification testing market, by region, 2018 - 2030 (USD Million)
- Table 44 Japan nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
- Table 45 Japan nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
- Table 46 Japan nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
- Table 47 China nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
- Table 48 China nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
- Table 49 China nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
- Table 50 India nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
- Table 51 India nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
- Table 52 India nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
- Table 53 Australia nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
- Table 54 Australia nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
- Table 55 Australia nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
- Table 56 Thailand nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
- Table 57 Thailand nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
- Table 58 Thailand nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
- Table 59 South Korea nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
- Table 60 South Korea nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
- Table 61 South Korea nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
- Table 62 Latin America nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
- Table 63 Latin America nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
- Table 64 Latin America nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
- Table 65 Latin America nucleic acid amplification testing market, by region, 2018 - 2030 (USD Million)
- Table 66 Brazil nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
- Table 67 Brazil nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
- Table 68 Brazil nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
- Table 69 Mexico nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
- Table 70 Mexico nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
- Table 71 Mexico nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
- Table 72 Argentina nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
- Table 73 Argentina nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
- Table 74 Argentina nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
- Table 75 Middle East and Africa nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
- Table 76 Middle East and Africa nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
- Table 77 Middle East and Africa nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
- Table 78 Middle East and Africa nucleic acid amplification testing market, by region, 2018 - 2030 (USD Million)
- Table 79 South Africa nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
- Table 80 South Africa nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
- Table 81 South Africa nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
- Table 82 Saudi Arabia nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
- Table 83 Saudi Arabia nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
- Table 84 Saudi Arabia nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
- Table 85 UAE nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
- Table 86 UAE nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
- Table 87 UAE nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
- Table 88 Kuwait nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
- Table 89 Kuwait nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
- Table 90 Kuwait nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
List of Figures
- Fig. 1 Market research process
- Fig. 2 Data triangulation techniques
- Fig. 3 Primary research pattern
- Fig. 4 Market research approaches
- Fig. 5 Value-chain-based sizing & forecasting
- Fig. 6 QFD modeling for market share assessment
- Fig. 7 Market formulation & validation
- Fig. 8 Nucleic acid amplification testing: Market outlook
- Fig. 9 Nucleic acid amplification testing: Competitive insights
- Fig. 10 Parent market outlook
- Fig. 11 Related/ancillary market outlook
- Fig. 12 Penetration and growth prospect mapping
- Fig. 13 Industry value chain analysis
- Fig. 14 Nucleic acid amplification testing market driver impact
- Fig. 15 Nucleic acid amplification testing market restraint impact
- Fig. 16 Nucleic acid amplification testing market strategic initiatives analysis
- Fig. 17 Nucleic acid amplification testing market: Type movement analysis
- Fig. 18 Nucleic acid amplification testing market: Type outlook and key takeaways
- Fig. 19 Polymerase chain reaction (PCR) tests market estimates and forecasts, 2018 - 2030
- Fig. 20 Isothermal nucleic acid amplification technology (INAAT) tests market estimates and forecasts, 2018 - 2030
- Fig. 21 Ligase chain reaction (LCR) tests market estimates and forecasts, 2018 - 2030
- Fig. 22 Nucleic acid amplification testing market: Application movement analysis
- Fig. 23 Nucleic acid amplification testing market: Application outlook and key takeaways
- Fig. 24 Infectious disease testing market estimates and forecasts, 2018 - 2030
- Fig. 25 Covid-19 testing market estimates and forecasts, 2018 - 2030
- Fig. 26 Mosquito borne disease testing market estimates and forecasts, 2018 - 2030
- Fig. 27 Influenza testing market estimates and forecasts, 2018 - 2030
- Fig. 28 Sexually transmitted infection testing market estimates and forecasts, 2018 - 2030
- Fig. 29 Hepatitis testing market estimates and forecasts, 2018 - 2030
- Fig. 30 Tuberculosis testing market estimates and forecasts, 2018 - 2030
- Fig. 31 Others testing market estimates and forecasts, 2018 - 2030
- Fig. 32 Oncology testing market estimates and forecasts, 2018 - 2030
- Fig. 33 Genetic & mitochondrial disease testing market estimates and forecasts, 2018 - 2030
- Fig. 34 Others testing market estimates and forecasts, 2018 - 2030
- Fig. 35 Nucleic acid amplification testing market: End-use movement analysis
- Fig. 36 Nucleic acid amplification testing market: End-use outlook and key takeaways
- Fig. 37 Hospitals market estimates and forecasts, 2018 - 2030
- Fig. 38 Central and reference laboratories market estimates and forecasts, 2018 - 2030
- Fig. 39 Others market estimates and forecasts, 2018 - 2030
- Fig. 40 Global nucleic acid amplification testing market: Regional movement analysis
- Fig. 41 Global nucleic acid amplification testing market: Regional outlook and key takeaways
- Fig. 42 North America market estimates and forecasts, 2018 - 2030
- Fig. 43 U.S. market estimates and forecasts, 2018 - 2030
- Fig. 44 Canada market estimates and forecasts, 2018 - 2030
- Fig. 45 Europe market estimates and forecasts, 2018 - 2030
- Fig. 46 UK market estimates and forecasts, 2018 - 2030
- Fig. 47 Germany market estimates and forecasts, 2018 - 2030
- Fig. 48 France market estimates and forecasts, 2018 - 2030
- Fig. 49 Italy market estimates and forecasts, 2018 - 2030
- Fig. 50 Spain market estimates and forecasts, 2018 - 2030
- Fig. 51 Denmark market estimates and forecasts, 2018 - 2030
- Fig. 52 Sweden market estimates and forecasts, 2018 - 2030
- Fig. 53 Norway market estimates and forecasts, 2018 - 2030
- Fig. 54 Asia Pacific market estimates and forecasts, 2018 - 2030
- Fig. 55 Japan market estimates and forecasts, 2018 - 2030
- Fig. 56 China market estimates and forecasts, 2018 - 2030
- Fig. 57 India market estimates and forecasts, 2018 - 2030
- Fig. 58 Australia market estimates and forecasts, 2018 - 2030
- Fig. 59 Thailand market estimates and forecasts, 2018 - 2030
- Fig. 60 South Korea market estimates and forecasts, 2018 - 2030
- Fig. 61 Latin America market estimates and forecasts, 2018 - 2030
- Fig. 62 Brazil market estimates and forecasts, 2018 - 2030
- Fig. 63 Mexico market estimates and forecasts, 2018 - 2030
- Fig. 64 Argentina market estimates and forecasts, 2018 - 2030
- Fig. 65 Middle East and Africa. market estimates and forecasts, 2018 - 2030
- Fig. 66 South Africa market estimates and forecasts, 2018 - 2030
- Fig. 67 Saudi Arabia market estimates and forecasts, 2018 - 2030
- Fig. 68 UAE market estimates and forecasts, 2018 - 2030
- Fig. 69 Kuwait market estimates and forecasts, 2018 - 2030
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.